Journal of the Korean Applied Science and Technology (한국응용과학기술학회지)

The Korean Society of Applied Science and Technology (한국응용과학기술학회)
권호 표지
DOI QR코드

DOI QR Code

Study on the N-Acetyl-D-glucosamine as the Anti-aging Cosmetic Ingredients

항노화 화장품 원료로서의 N-Acetyl-D-glucosamine에 관한 연구

  • 표영희 (오산대학 뷰티디자인계열) ;
  • 김영은 (서울호서전문학교 미용학과) ;
  • 문지선 (중원대학교 뷰티헬스학과)
  • Received : 2016.10.26
  • Accepted : 2016.12.23
  • Published : 2016.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

In this study we applied the NAG obtained by the deacetylation of chitin extracted from the shells of crabs and shrimp as cosmetic ingredient. In order to compare NAG with GLC we identified the influence of cytotoxicity, anti-inflammatory, melanin biosynthesis formation inhibition on skin cell, and we measured the effects of the change of melanin and red spots. The results show that there was not any attentive cytotoxicity on the Raw 264.7 cell and B16F10 cell, and NO formation anti-inflammatory hindrance effect induced from Raw 264.7 by LPS was slight, and NAG suppressed the increase of melanin generation concentration-dependently after we induced the melanin generation with ${\alpha}$-MSH on B16F10 and measured the melanin biosynthesis inhibition. From this result, we identified the applicability of the cosmetics containing NAG as functional cosmetic for enhancing skin-lightening because when cream containing NAG was applied to skin the index of melanin red spots showed statistically meaningful changes.

본 연구에서는 게나 새우의 껍데기에서 추출된 키틴을 탈아세틸화 하여 얻은 NAG를 화장품 원료로서 적용하고자 하였다. NAG와 GLC를 비교하기 위하여 피부세포에 대한 세포독성, 항염증, 멜라닌 생합성 억제능에 미치는 영향을 확인하고, 피부에 적용하였을 때 멜라닌과 홍반변화의 효과를 측정하였다. 연구 결과 Raw 264.7세포와 B16F10세포에 대해 유의한 세포독성을 나타나지 않았으며, Raw 264.7세포에서 LPS에 의해 유도된 NO 생성 항염증 저해효과는 미비 하였고, NAG는 B16F10세포에 ${\alpha}$-MSH로 멜라닌 생성을 유도한 후 멜라닌 생합성 억제능을 측정한 결과 멜라닌의 생성 증가를 농도 의존적으로 억제되는 것을 확인하였다. 이와 같은 결과로 NAG가 함유된 크림을 만들어 피부에 적용하였을 때 멜라닌 지수, 홍반지수의 감소가 통계적으로 유의미한 변화를 보여 NAG 함유 화장품이 피부미백개선을 위한 기능성화장품으로 활용 가능성을 확인할 수 있었다.

Keywords

References

  1. B. Sonali , MK. Bosena, Preparation and characterization of lipid based nanosystems for topical delivery of quercetin. Eur J. Pharm Sci. 40, 442-452. (2013).
  2. D.H Kim, N.H, Park, T,I, Son, J.W, Lee, J.S, Na. The Analysis on the Recent Patent Trend of Chitosan and Glucosamone. J. Chitin, Chitosan, 14(4), 182-187 (2009).
  3. J.Y, Kim, Development of N-acetylglucosamine-producing Microorganism. Department of Pharmacy Graduate School Kyungsung University (2016).
  4. K.S, Kim, G.H, Choi, J.W, Choi, J. Hak, H.S, Hee, N.S, Yun, L.S, Hwa. Anti-wrinkle Effect of N-Acetyl-D-glucosamine (NAG). J. Soc. Cosmet. Scientists Korea, 30(4), 457-462 (2004).
  5. C, Park, KH, Chung, Jeong TR, Yang HP, Nam KS, Kim CH. Effects of N-acetylglucosamine on suppression of collagenolysis and bone resorption in mouse calvarial osteoblasts. J. Chitin. Chitosan, 5, 79-87 (2000).
  6. JK, Chen, CR, Shen, CL, Liu. N-acetylglucosamine: production and applications. Mar Drugs, 8, 2493-2516 (2010). https://doi.org/10.3390/md8092493
  7. T, Sayo, S, Sakai, S, Inoue. Synergistic effect of N-acetylglucosamine and retinoids on hyaluronan production in human keratinocytes. Skin Phamacol Physiol., 17, 77-83 (2004). https://doi.org/10.1159/000076017
  8. T. Sayo, S. S.akai, and S. Inoue, Regulation of hyalronan synthesis in keratinocytes and its modulator, IFSCC, (2002).
  9. T.J, Yoon., Study on the Whitening Effect of N-Acetyl Glucosamine (NAG). Health & Medical Technology R&D Program, A080309, (2010).
  10. G, Crolle, E. D'Este, Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation. Curr Med Res Opin., 7, 104-109 (1980). https://doi.org/10.1185/03007998009112035
  11. DR, Runkel, MJ, Cupp, Glucosamine sulfate use in osteoarthritis. Am. J. Heath Syst Pharm, 56, 267-269 (1999).
  12. S. Dahmer, RM. Schiller. Glucosamine. American Family Physicia, 78, 471-476 (2008).
  13. J.H. Quastel, A. Cantero. Inhibition of tumour growth by D-glucosamine. Nature, 171, 252-254 (1953). https://doi.org/10.1038/171252a0
  14. SJ. Friedman, P. Skehan. Membrane-active drugs potentiate the killing of tumor cells by D-glucosamine. Proc. Nat.l Acad. Sci. USA, 77, 1172-1176 (1980). https://doi.org/10.1073/pnas.77.2.1172
  15. R.A. Korhonen, H.E. Lahti Kankaanranta, Moilanen. Nitric oxide production and signaling in inflammation. Curr. J. Drug Targets, Inflamm. Allergy., 4, 471 (2005). https://doi.org/10.2174/1568010054526359
  16. J. MacMicking, Q. W. Xie, C. Nathan. Nitric oxide and macrophage function. Annu Rev. Immunol., 15, 323 (1997). https://doi.org/10.1146/annurev.immunol.15.1.323
  17. P. Forsythe, M. Gilchrist, M. Kulka, A. D. Befus, Mast cells and nitric oxide: control of production, mechanisms of response. Int. Immunopharmacol., 1(8), 1525 (2001). https://doi.org/10.1016/S1567-5769(01)00096-0
  18. K. Kobayashi, T. Akao, M. Kanaoka, Metabolism of ginsenoside by human intestinal bacteria(II). J. Ginseng. Res., 11, 1(1994).
  19. W.S. Oetting, J.P. Fryer, R.A. King, Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCAI) mutations in brief No.204 online. J. Human Mutation., 12, 433(1988).
  20. A. Breborowicz, M. Kuzlan-Pawlaczyk, K. Wieczorowska-Tobis, J. Wisniewska, P. Tam, I. French, G. Wu, The effect of N-acetylglucosamine as a substrate for in vitro synthesis of glycosaminoglycans by human peritoneal mesothelial cells and fibroblasts. Adv. Perit. Dial. 14, 31-35 (1998)
  21. J.K. Chen, C.R. Shen, C.L. Liu, N-acetylglucosamine: production and applications. Mar. Drugs. 8, 2493-2516 (2010). https://doi.org/10.3390/md8092493
  22. M. Nakamura, M. Hikida, T. Nakano, S. Ito, T. Hamano, S. Kinoshita, Characterization of water retentive properties of hyaluronan. Cornea, 12, 433-436 (1993). https://doi.org/10.1097/00003226-199309000-00010
  23. S.J. Ashcroft, M.C. Sugden, I.H. Williams, Carbohydrate metabolism and the glucoreceptor metabolism. Horm. Metab. Res. Suppl. 10, 1-7 (1980).
  24. J.K. Chen, C.R. Shen, C.L. Liu, N-acetylglucosamine: production and applications. Mar. Drugs, 8, 2493-2516. (2010). https://doi.org/10.3390/md8092493
  25. M. Kamel, M. Hanafi, M. Bassiouni. Inhibition of elastase enzyme release from huma polymorphonuclear leukocytes by N-acetylglucosamine and N-acetylgalactosamine. Clin. Exp. Rheumotol, 9(1), 17-21 (1991).
  26. J.H. Kim, J.M Lim, J.T. Jang, H.P. Yang. Studies on the Biological Activity of N-acetylglucosamine. J. Kor. Soc. Cosm, 12(1), 21-29 (2006).